Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02780011 |
|---|---|
| Brief Title: | Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies (AD3LE) |
| First Submitted : | February 24, 2016 |
| First Submitted that Met QC Criteria : | May 20, 2016 |
| First Posted : | May 23, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 25, 2018 |
| Last Update Posted : | July 27, 2018 |